Myriad Genetics has commercially launched FirstGene Multiple Prenatal Screen, a lab-developed test that combines four prenatal genetic screens in one blood draw

Myriad Genetics has commercially launched FirstGene Multiple Prenatal Screen, a lab-developed test that combines four prenatal genetic screens in one blood draw. Available from eight weeks of gestation, it expands Myriad’s clinical testing portfolio.